Skip to Content


April issue now online – next big buying opportunity inside

March 29, 2012, 11:01 am

I just posted the latest issue of GameChangers on our website, and I hope you’ll take a few moments to read it right away.

I’ve uncovered a brand-new defense stock pick that will be immune to budget cuts and reductions in defense spending… and is sure to rack up some huge profits for us in the months ahead.

You see, with defense stocks, it’s all about being in the right segment of the industry, and this stock is a leader in one of the most promising areas – unmanned aerial vehicles (UAVs). UAVs are playing key roles in the wars in Iraq and Afghanistan, where they are used for everything from hunting targets to protecting forces to watching warehouses. According to Brigadier General Kevin Mangum, the demand for UAVs from troops is insatiable, and the military is finding new uses for them all the time. Total expenditures on UAVs are expected to double in the next decade to $11.3 billion.

My #1 pick–announced in this issue–is a leader in the manufacturing of UAVs and perfectly positioned to profit from the soaring growth in this field. The company also has a small but potentially GameChanging and lucrative division that is focused on efficient energy solutions, primarily making refueling systems for fleet and electric vehicles. I’m targeting a gain of 50% from current prices. Get its name now.

GameChangers subscribers just locked in 54% profits last week in Mako Surgical, and the week before that we sold Ariad Pharmaceuticals for 85% gains and Novo Nordisk for 33% gains.

Overall, our portfolio is on a tear. So far this year, we have an incredible FOURTEEN stocks up 15% or more. Don’t miss out on the next round of profits ahead!

In addition to this lucrative new UAV recommendation, I also reveal the name of another defense stock that looks attractive, plus 3 other stocks that are excellent buys right now. Read the current issue of GameChangers today and join in on the fun.

Be the first to leave a comment.

* Required. Email address will not be shared.

By submitting a comment you grant Kramer Capital Research a perpetual license to reproduce your words and name/web site in attribution. Inappropriate and irrelevant comments will be removed at an admin’s discretion. Your email is used for verification purposes only, it will never be shared. Please note that comments will be not be responded to directly on this website, but may be addressed through future articles and other content.